Radek Gažák

2.1k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

Radek Gažák is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Radek Gažák has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Pulmonary and Respiratory Medicine and 23 papers in Pharmacology. Recurrent topics in Radek Gažák's work include Silymarin and Mushroom Poisoning (26 papers), Synthesis and bioactivity of alkaloids (15 papers) and Berberine and alkaloids research (9 papers). Radek Gažák is often cited by papers focused on Silymarin and Mushroom Poisoning (26 papers), Synthesis and bioactivity of alkaloids (15 papers) and Berberine and alkaloids research (9 papers). Radek Gažák collaborates with scholars based in Czechia, Italy and Belgium. Radek Gažák's co-authors include Vladimı́r Křen, Daniela Walterová, Petr Sedmera, Petr Marhol, Alena Rajnochová Svobodová, Jitka Psotová, Marek Kuzma, David Biedermann, Patrick Trouillas and Jitka Vostálová and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Radek Gažák

41 papers receiving 1.8k citations

Hit Papers

Silybin and Silymarin - New and Emerging Applications in ... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers

Radek Gažák
Radek Gažák
Citations per year, relative to Radek Gažák Radek Gažák (= 1×) peers David Biedermann

Countries citing papers authored by Radek Gažák

Since Specialization
Citations

This map shows the geographic impact of Radek Gažák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radek Gažák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radek Gažák more than expected).

Fields of papers citing papers by Radek Gažák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radek Gažák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radek Gažák. The network helps show where Radek Gažák may publish in the future.

Co-authorship network of co-authors of Radek Gažák

This figure shows the co-authorship network connecting the top 25 collaborators of Radek Gažák. A scholar is included among the top collaborators of Radek Gažák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radek Gažák. Radek Gažák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vimberg, Vladimir, Radek Gažák, Anikó Borbás, et al.. (2018). Fluorescence assay to predict activity of the glycopeptide antibiotics. The Journal of Antibiotics. 72(2). 114–117. 11 indexed citations
2.
Gažák, Radek, et al.. (2017). Evolution-guided adaptation of an adenylation domain substrate specificity to an unusual amino acid. PLoS ONE. 12(12). e0189684–e0189684. 5 indexed citations
3.
Najmanová, Lucie, Dana Ulanová, M. Jelı́nková, et al.. (2014). Sequence analysis of porothramycin biosynthetic gene cluster. Folia Microbiologica. 59(6). 543–552. 23 indexed citations
4.
Gažák, Radek, David Biedermann, Florent Di Meo, et al.. (2014). cistrans Isomerization of silybins A and B. Beilstein Journal of Organic Chemistry. 10. 1047–1063. 14 indexed citations
5.
Gažák, Radek, Gour Chand Daskhan, Julian Garcia, et al.. (2014). Access to bifunctionalized biomolecular platforms using oxime ligation. Carbohydrate Research. 393. 9–14. 6 indexed citations
6.
Kučera, Tomáš, Dominika Chalupská, Radek Gažák, et al.. (2013). Adaptation of an L-Proline Adenylation Domain to Use 4-Propyl-L-Proline in the Evolution of Lincosamide Biosynthesis. PLoS ONE. 8(12). e84902–e84902. 20 indexed citations
7.
Agarwal, Chapla, Gagan Deep, David Biedermann, et al.. (2013). Anti-Cancer Efficacy of Silybin Derivatives - A Structure-Activity Relationship. PLoS ONE. 8(3). e60074–e60074. 57 indexed citations
8.
Košinová, Pavlína, Radek Gažák, Jean‐Luc Duroux, et al.. (2011). Dimerisation Process of Silybin‐Type Flavonolignans: Insights from Theory. ChemPhysChem. 12(6). 1135–1142. 11 indexed citations
9.
Marhol, Petr, Radek Gažák, Petr Bednář, & Vladimı́r Křen. (2011). Narrow‐bore core–shell particles and monolithic columns in the analysis of silybin diastereoisomers. Journal of Separation Science. 34(16-17). 2206–2213. 15 indexed citations
10.
Zatloukalová, Martina, Vladimı́r Křen, Radek Gažák, et al.. (2011). Electrochemical investigation of flavonolignans and study of their interactions with DNA in the presence of Cu(II). Bioelectrochemistry. 82(2). 117–124. 48 indexed citations
11.
Bojarová, Pavla, Kristýna Slámová, Karel Křenek, et al.. (2011). Charged Hexosaminides as New Substrates for β‐N‐Acetylhexosaminidase‐Catalyzed Synthesis of Immunomodulatory Disaccharides. Advanced Synthesis & Catalysis. 353(13). 2409–2420. 31 indexed citations
12.
Ježek, Jan, Martin Jabůrek, Radek Gažák, et al.. (2010). Effect of flavonolignans derived from silybin on mitochondrial production of reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1797. 60–60. 1 indexed citations
13.
Vostálová, Jitka, et al.. (2010). Cardioprotective activity of dehydrosilybin is linked to its uncoupler-like behavior. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1797. 87–87. 1 indexed citations
14.
Slámová, Kristýna, Radek Gažák, Pavla Bojarová, et al.. (2010). 4-Deoxy-substrates for β-N-acetylhexosaminidases: How to make use of their loose specificity. Glycobiology. 20(8). 1002–1009. 34 indexed citations
15.
Jabůrek, Martin, Radek Gažák, Jitka Vostálová, et al.. (2010). Dehydrosilybin attenuates the production of ROS in rat cardiomyocyte mitochondria with an uncoupler-like mechanism. Journal of Bioenergetics and Biomembranes. 42(6). 499–509. 21 indexed citations
16.
Gažák, Radek, Kateřina Purchartová, Petr Marhol, et al.. (2009). Antioxidant and antiviral activities of silybin fatty acid conjugates. European Journal of Medicinal Chemistry. 45(3). 1059–1067. 53 indexed citations
17.
Gažák, Radek, Daniela Walterová, & Vladimı́r Křen. (2007). Silybin and Silymarin - New and Emerging Applications in Medicine. Current Medicinal Chemistry. 14(3). 315–338. 501 indexed citations breakdown →
18.
Džubák, Petr, Marián Hajdúch, Radek Gažák, et al.. (2006). New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity. Bioorganic & Medicinal Chemistry. 14(11). 3793–3810. 70 indexed citations
19.
Plíšková, Martina, Jan Vondráček, Vladimı́r Křen, et al.. (2005). Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation. Toxicology. 215(1-2). 80–89. 71 indexed citations
20.
Gažák, Radek, Alena Rajnochová Svobodová, Jitka Psotová, et al.. (2004). Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorganic & Medicinal Chemistry. 12(21). 5677–5687. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026